MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told
In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending
Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher
Manipulating The Therapeutic Index Clinical Trials Goal: Hellman
NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen
HHS Carcinogen Guidelines Draft
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Galleri MCD vote: What FDA asked its advisors to ignore









